MarshallB.ElamMD
Cardiology • Memphis, TNAdult Congenital Heart Disease
Professor of Pharmacology and Medicine, Director, Lipid Metabolism Clinics, VAMC, University of Tennessee Health Science Center College of Medicine
Dr. Elam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1030 Jefferson Ave
Memphis Va Hypertension/Lipid Research Clinic 111q
Memphis, TN 38104Phone+1 901-523-8990Fax+1 901-448-7206
Education & Training
University of TennesseeFellowship, Cardiovascular Disease, 1982 - 1985- University of TennesseeResidency, Internal Medicine, 1979 - 1982
University of Tennessee Health Science Center College of MedicineClass of 1982
Certifications & Licensure
TN State Medical License 1981 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 37 citationsEffect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Interventio...Carolyn M. Chesney, Marshall B. Elam, J.Alan Herd, Kathryn B. Davis, Rekha Garg
American Heart Journal. 2000-10-01 - 2408 citationsGemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolHanna Bloomfield Rubins, Sander J. Robins, Dorothea Collins, Carol L. Fye, James W. Anderson
The New England Journal of Medicine. 1999-08-05 - 35 citationsRole of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective.Marshall B. Elam, Laura C. Lovato, Henry N. Ginsberg
Current Opinion in Lipidology. 2011-02-01
Journal Articles
- Trial Designs Rationale and Design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) Study☆Marshall Elam, Aruna D Pradhan, William R Hiatt, ScienceDirect
Grant Support
- Molecular Mechanisms Of Mitigation Of Insulin Induction Of SREBP-1C By N-3 PUFAVeterans Affairs2011–2012
- Regulation Of SREBP-1C Processing By Insulin And Cyclic-AmpNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Assessment Of Androgenic Hormones In Patients With Coronary Heart DiseaseNational Center For Research Resources1998–2001
- Atherosclerotic Multifactorial Disease Trial--AdmitNational Center For Research Resources1995–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
